Who is sponsoring NCT05577520?

NCT05577520 is sponsored by Universidad del Salvador, Argentina.

What drugs are being tested in NCT05577520?

Interventions in NCT05577520: Sinus floor augmentation.

What condition does NCT05577520 study?

NCT05577520 studies Maxillary Sinus Augmentation.

Is NCT05577520 still recruiting?

NCT05577520 is currently completed. Last updated 13 October 2022.

Last reviewed 2022-10-13 · How we verify

NCT05577520

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Maxillary Sinus Augmentation Using Different Size Bovine Bone Particles

Completed NA Last updated 13 October 2022

What this trial tests

NA trial testing Sinus floor augmentation in Maxillary Sinus Augmentation in 20 participants. Completed in 30 August 2019.

Timeline

1 March 2016

Primary endpoint
25 February 2018

30 August 2019

Quick facts

Lead sponsor	Universidad del Salvador, Argentina
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	1 March 2016
Primary completion	25 February 2018
Estimated completion	30 August 2019
Sites	1 location across Argentina

Drugs / interventions tested

Sinus floor augmentation

Conditions studied

Maxillary Sinus Augmentation — all drugs for Maxillary Sinus Augmentation →

Sponsor

Universidad del Salvador, Argentina

Who can join

21 and older, any sex, with Maxillary Sinus Augmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The decrease in maxillary alveolar ridge bone volume and sinus pneumatization are a challenge to implant-assisted prosthetic rehabilitation. Guided bone regeneration using bone substitutes is an adequate alternative for maxillary sinus augmentation. Objective: To histologically and histomorphometrically compare bone repair response to 250 to 1000 µm and 1000 to 2000 µm anorganic bovine bone mineral (ABBM) particles as bone substitute in maxillary sinus augmentation (MSA).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sinus floor augmentation

Trials testing the same drug.

NCT04543630 — Maxillary Sinus Floor Augmentation in Diabetic Patients · NA · not yet recruiting
NCT03496688 — Comparative Results of Six Biomaterials Used in Two-stage Maxillary Sinus · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05577520 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad del Salvador, Argentina
Last refreshed: 13 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05577520.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing